MedTrace Logo

Risk Indicators of Sarcoidosis Evolution-Unified Protocol

NCT05567133 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-01-08

No results posted yet for this study

Summary

The purpose of this study is to develop prediction models that can prognosticate patients with sarcoidosis using clinical data and blood markers that can be obtained during a clinic visit.

Conditions

  • Sarcoidosis, Pulmonary

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    collaborator OTHER

  • University of Texas, Southwestern Medical Center at Dallas

    collaborator OTHER

  • Wayne State University

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Laura Koth · University of California, San Francisco

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2030-03-30
Completion
2030-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05567133 on ClinicalTrials.gov